Stromal Cell Recruitment and the Pathogenesis of Metastasis
基质细胞的募集和转移的发病机制
基本信息
- 批准号:8555485
- 负责人:
- 金额:$ 20.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-23 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesAutomobile DrivingBehaviorBiologicalBlood CirculationBreast Cancer CellBreast CarcinomaCSF3 geneCarcinomaCellsChemotactic FactorsComplexDisseminated Malignant NeoplasmEndocrineEnzyme-Linked Immunosorbent AssayEpithelialExtravasationHumanImplantLaboratoriesMalignant - descriptorMalignant Epithelial CellMalignant NeoplasmsMesenchymalMusMyeloid CellsNatureNeoplasm MetastasisOrganParacrine CommunicationPathogenesisPlayPrimary NeoplasmProductionRecruitment ActivityRelapseResearchRoleSignal TransductionSnailsSourceSpleenSplenectomySplenomegalyStromal CellsTestingTumor Volumecancer cellcell stromacell typeextracellularimplantationin vivomacrophagemalignant statemonocyteneoplastic cellneutrophilparacrineprogramsrelease factorsuccesstraittranscription factortumortumor progression
项目摘要
The acquisition of highly malignant traits by carcinoma cells enables their invasion and metastatic
dissemination. In many, and possibly all carcinomas, these traits are conferred by a cell-biological program
termed the epithelial-mesenchymal transition (EMT). The EMT program is induced in carcinoma cells, usually
reversibly, by contextual signals that they receive, largely if not entirely from the adjacent reactive stroma that
is present in many highly progressed tumors. While the intracellular signaling circuits that enable activation of
EMT programs have come into view, the nature of the extracellular, contextual signals that activate these
programs in carcinoma cells is still obscure as are the cellular origins of these signals. This Indicates that the
ultimate governors of malignant progression - the stromal cells and the signals that they release - are still
poorly understood.
The proposed research derives from the convergence of two lines of research in the Pi's laboratory. First.
Twist - an EMT-inducing transcription factor - is responsible for the malignant behavior of highly aggressive
4T1 mouse mammary carcinoma cells; its expression is induced in vivo, ostensibly by signals that the
implanted 4T1 cells receive from the stromal cells that they recruit. Second, these carcinoma cells induce
splenomegaly in tumor-bearing syngeneic mouse hosts. Rather than being an epiphenomenon of tumor
pathogenesis, this splenomegaly plays a causal role in 4T1 tumor formation, since in the absence of a
functional spleen (achieved by splenectomy), the expression of the Twist and Snail EMT-TFs and their ability
to spawn metastases are all significantly reduced. Hence, the local malignant state of these tumors, and likely
many other tumors, is controlled by systemic factors, in this case myeloid cells recruited from the spleen.
These dynamics suggest that certain carcinomas, such as the 4T1 tumors studied here, induce
splenomegaly; the myeloid cells that collect In the spleen may then be recruited via the circulation into the
tumor-associated stroma, where these cells proceed to release heterotypic signals that induce an EMT in the
4T1 cells, enabling the latter to metastasize. Importantly for the proposed research, the spleens of these mice
should represent a rich source of the myeloid cells that participate in the induction of the EMT and thus in the
triggering of metastatic relapse. The research that is proposed will examine these cells as well as others that
are recruited into the tumor-associated stroma in order to develop a list of the functionally important,
malignancy-promoting cells in the tumor-associated stroma and to uncover the EMT-inducing paracrine signals
that they release.
癌细胞对高度恶性特征的获取可实现其侵袭和转移性
传播。在许多(甚至所有癌)中,这些特征是由细胞生物学程序赋予的
称为上皮 - 间质转变(EMT)。 EMT程序在癌细胞中诱导,通常
可逆地,通过他们收到的上下文信号,很大程度上甚至不是完全来自相邻的反应性基质
存在于许多高度进展的肿瘤中。而细胞内信号传导电路可以激活
EMT程序已经开始了,细胞外,上下文信号的性质激活这些信号
癌细胞中的程序仍然是晦涩的,这些信号的细胞起源也是如此。这表明
恶性进展的最终调速器 - 基质细胞及其释放的信号 - 仍然是
理解不佳。
提出的研究源于PI实验室中两条研究线的收敛。第一的。
扭曲 - 诱导EMT的转录因子 - 负责高度侵略性的恶性行为
4T1小鼠乳腺癌细胞;它的表达在体内诱导,表面上是通过信号表明
植入的4T1细胞从其募集的基质细胞中接收。其次,这些癌细胞诱导
具有肿瘤的同性小鼠宿主中的脾肿大。而不是作为肿瘤的表皮
发病机理,这种脾肿大在4T1肿瘤形成中起因果作用,因为在没有A的情况下
功能性脾脏(通过脾切除术实现),扭曲和蜗牛EMT-TF的表达及其能力
产卵转移均大大减少。因此,这些肿瘤的局部恶性状态,可能
许多其他肿瘤受系统因素控制,在这种情况下,从脾脏募集的髓样细胞。
这些动力学表明某些癌,例如这里研究的4T1肿瘤,诱导
脾肿大;然后可以通过循环招募在脾脏中收集的髓样细胞
肿瘤相关的基质,这些细胞继续释放诱导EMT的异型信号
4T1细胞,使后者能够转移。重要的是,对于拟议的研究,这些小鼠的脾脏
应代表参与EMT诱导的髓样细胞的丰富来源,因此
触发转移性复发。提出的研究将检查这些细胞以及其他细胞
被招募到与肿瘤相关的基质中,以制定功能上重要的列表
肿瘤相关的基质中的恶性细胞,并发现EMT诱导的旁分泌信号
他们释放。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A WEINBERG其他文献
ROBERT A WEINBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A WEINBERG', 18)}}的其他基金
Induction of Mesechymal and Stem-Cell Traits in Breast Cancer Cells Via Heteroty
通过杂性诱导乳腺癌细胞间充质和干细胞特征
- 批准号:
8633703 - 财政年份:2014
- 资助金额:
$ 20.53万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 20.53万 - 项目类别:
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes
丝氨酸蛋白酶 HTRA1 抗原:阐明膜性肾病发病机制和抗原表位靶向的途径
- 批准号:
10740614 - 财政年份:2023
- 资助金额:
$ 20.53万 - 项目类别:
Development of a targeted TGF-b therapeutic that selectively blocks lung fibrosis in idiopathic pulmonary fibrosis (IPF) patients
开发选择性阻断特发性肺纤维化 (IPF) 患者肺纤维化的靶向 TGF-b 疗法
- 批准号:
10697961 - 财政年份:2023
- 资助金额:
$ 20.53万 - 项目类别:
Bispecific immunotherapeutic delivery system for lung diseases
用于肺部疾病的双特异性免疫治疗递送系统
- 批准号:
10720773 - 财政年份:2023
- 资助金额:
$ 20.53万 - 项目类别:
Project 2: Microbial determinants of HIV broadly-neutralizing antibody precursor induction in infants
项目2:婴儿中HIV广泛中和抗体前体诱导的微生物决定因素
- 批准号:
10731282 - 财政年份:2023
- 资助金额:
$ 20.53万 - 项目类别: